MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Treatment"

  • 2018 International Congress

    Phenomenology and management of subthalamic stimulation-induced dyskinesia in a video case series of patients with isolated dystonia

    K. Dodenhoff, I. Bledsoe, M. San Luciano, M. Volz, L. Markun, P. Starr, J. Ostrem (San Francisco, CA, USA)

    Objective: To document with videotaped observations, 3 patients with isolated dystonia who experienced stimulation-induced dyskinesia (SID) following subthalamic nucleus (STN) deep brain stimulation (DBS). Background:…
  • 2018 International Congress

    Effect of lidocaine injection into the external oblique muscle on camptocormia and the lateral slant posture in patient with Parkinson’s disease

    Y. Higashi, M. Tabata, T. Tabuchi, Y. Hattori (Himeji, Japan)

    Objective: Camptocormia (CC) is one of the abnormal posture of Parkinson's disease (PD) patients, described as a severe forward flexion of the trunk. In this…
  • 2018 International Congress

    Response to botulinum toxin in adult onset lower limb dystonia

    D. Ehrlich, K. Alter, B. Karp (Bethesda, MD, USA)

    Objective: To describe the response to treatment with botulinum toxin in a cohort with adult onset lower limb dystonia. Background: Adult onset, lower limb dystonia…
  • 2018 International Congress

    Botulinum toxin injection for Pisa syndrome in Parkinson’s disease

    CA. Artusi, M. Zibetti, P. Barbero, M. Busso, S. Bortolani, S. De Mercanti, P. Arnoffi, M. Fabbri, A. Merola, L. Lopiano (Torino, Italy)

    Objective: We sought to assess the clinical efficacy of Botulinum toxin (BoNT) injection for Pisa syndrome (PS) using a combined Magnetic Resonance Imaging (MRI)-, Ultrasonography…
  • 2018 International Congress

    Paroxysmal multifocal dystonia with hemiplegic migraine possibly related to novel CACNA1A mutation

    A. Hannoun, K. Smith (Worcester, MA, USA)

    Objective: To report a case of a unique clinical presentation of hemiplegic migraine associated with paroxysmal multifocal dystonia possibly related to a novel CACNA1A mutation.…
  • 2018 International Congress

    Movement Disorders as Postinfectious Neurologic Syndromes

    H. Mori (Kurashiki, Okayama, Japan)

    Objective: We shows the three patients which some neurologists diagnosed psychological disorders at first. Their movement disorders are due to postinfectious neurologic syndromes (Epstein-Barr virus…
  • 2018 International Congress

    Zolpidem effect in task specific dystonia – clinical and neurophysiological study

    K. Vogelnik, M. Grmek, R. Perellon Alfonso, P. Tomše, M. Trošt, M. Kojović (Ljubljana, Slovenia)

    Objective: We conducted a double blind, placebo-controlled crossover study to examine clinical and neurophysiological effect of zolpidem in patients with task specific dystonia. Background: Task…
  • 2018 International Congress

    Deep brain stimulation matters in pediatric neurology – single-center experience

    M. Freilinger, A. Zeitlberger, S. Siegert, R. Seidl, F. Alesch, G. Kranz, K. Novak (Vienna, Austria)

    Objective: This study is to review our single-center experience with deep brain stimulation (DBS) in pediatric patients with dystonia. Background: Deep brain stimulation (DBS) is…
  • 2018 International Congress

    Pilot trial of botulinum toxin and occupational therapy for Writer’s Cramp

    J. Park, E. Shamim, O. Panyakaew, P. Mathew, C. Toro, J. Sackett, B. Karp, C. Lungu, K. Alter, B. Hodsdon, M. Villegas, T. Wu, O. Ahmad, P. Srivanitchapoom, S. Auh, M. (Goyang, Republic of Korea)

    Objective: We aimed to compare the effects of botulinum toxin (BoNT) therapy alone with a combination of BoNT and occupational therapy on patients with writer’s…
  • 2018 International Congress

    A Randomized Trial of Deferiprone for Pantothenate Kinase-Associated Neurodegeneration

    T. Klopstock, F. Tricta, L. Neumayr, I. Karin, G. Zorzi, C. Fradette, T. Kmieć, B. Buechner, H. Steele, R. Horvath, P. Chinnery, A. Basu, C. Küpper, C. Neuhofer, P. Dušek, F. Zhao, F. Zibordi, N. Nardocci, C. Aguilar, S. Hayflick, M. Spino, A. Blamire, P. Hogarth, E. Vichinsky (Munich, Germany)

    Objective: To investigate whether treatment with the iron-chelating drug deferiprone (DFP) has benefit in patients with pantothenate kinase-associated neurodegeneration (PKAN), the most common form of…
  • « Previous Page
  • 1
  • …
  • 30
  • 31
  • 32
  • 33
  • 34
  • …
  • 43
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley